McConkey v. McGhan Medical Corp.

144 F. Supp. 2d 958, 2000 U.S. Dist. LEXIS 19895, 2000 WL 33281615
CourtDistrict Court, E.D. Tennessee
DecidedJuly 6, 2000
Docket1:98-cr-00003
StatusPublished
Cited by2 cases

This text of 144 F. Supp. 2d 958 (McConkey v. McGhan Medical Corp.) is published on Counsel Stack Legal Research, covering District Court, E.D. Tennessee primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
McConkey v. McGhan Medical Corp., 144 F. Supp. 2d 958, 2000 U.S. Dist. LEXIS 19895, 2000 WL 33281615 (E.D. Tenn. 2000).

Opinion

*961 MEMORANDUM OPINION

JARVIS, District Judge.

This is a products liability action brought by plaintiffs Don and Mary Grace McConkey against McGhan Medical Corporation, Nusil Technology, and Minnesota Mining and Manufacturing Company (hereinafter “3M”) for damages sustained by their alleged part in the production and supply of silicone breast implants. Currently pending is 3M’s motion for summary judgment [Court File # 15]. For the reasons below, 3M’s motion regarding all claims will be granted.

I.

Factual Background

The following factual allegations are considered in the light most favorable to the plaintiff.

McGhan Medical Corporation (McGhan I) was incorporated on November 20, 1974 and began marketing a line of silicone breast implants in early 1975. In June of 1977, 3M acquired all assets of McGhan I and transferred them to a newly created subsidiary of 3M which was also named McGhan Medical Corporation (McGhan II). In 1980, McGhan II was merged into 3M and became a department in 3M’s Surgical Products Division.

In 1984, with concerns mounting over future tort liability relating to breast implant production, 3M sold its breast implant business to a newly created McGhan Medical Corporation (McGhan III). The founder of McGhan I and other investors had formed McGhan III. 3M provided McGhan III with a substantial portion of the $5.5 million dollar purchase price via a loan to the new company. 3M then stopped making breast implants.

In 1985, McGhan III became a wholly owned subsidiary of First American Corporation (later renamed “INAMED”). INAMED then defaulted on the loan it had acquired through its purchase of McGhan III. 3M agreed to restructure the loan and then threatened INAMED with litigation when they again defaulted on the loan.

Mary McConkey was implanted with a McGhan silicone breast implant on August 12, 1988. On November 22, 1988, her implant was replaced with another McGhan implant. Finally, on September 9, 1991, her implant was again replaced by another McGhan implant. Mary McConkey then brought suit alleging that the implants caused her physical and emotional damages. Her husband, Don McConkey, also sued claiming loss of consortium and damages relating to medical expenses incurred due to his wife’s injuries.

II.

Summary Judgment Standards

A party is entitled to have a judgment in its favor “rendered forthwith if the pleadings, depositions, answers to interrogatories, and admissions on file, together with the affidavits, if any, show there is no genuine issue as to any material fact and that the moving party is entitled to judgment as a matter of law.” Fed.R.Civ.P. 56(c). Summary judgment is intended to provide a quick, inexpensive means of resolving issues as to which there is no dispute regarding the material facts. Celotex Corp. v. Catrett, 477 U.S. 317, 106 S.Ct. 2548, 91 L.Ed.2d 265 (1986). In assessing the validity of a summary judgment motion, the court views the pleadings, depositions, answers to interrogatories, admissions, and competent affidavits in a light most favorable to the opponent of the motion. Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 106 S.Ct. 2505, 91 L.Ed.2d 202 (1986). Rule 56 mandates entry of a summary judgment, after adequate time for *962 discovery and upon motion, against a party who fails to make a showing sufficient to establish the existence of an essential element of that party’s case, and on which the party will bear the burden of proof at trial. Catrett, 477 U.S. at 322, 106 S.Ct. 2548. One of the primary purposes of the summary judgment rule is to isolate and dispose of factually unsupported claims. Id. at 323-24,106 S.Ct. 2548.

III.

Parent/Subsidiary Liability

Plaintiffs claim that, because McGhan III acted under the power of 3M, the liability for production of breast implants by McGhan III may be attributed to 3M. However, Plaintiffs have failed to prove what strings ran from the hand of 3M to the “puppet” McGhan III that would justify piercing the corporate veil.

A corporation is usually treated as a separate entity. Post Sign Co. v. Jerne’s, Inc., 48 TennApp. 13, 342 S.W.2d 385, 390 (1960); see 18 Am.Jur.2d, Corporations § 42 at 840 (1985). This presumption, however, will be quickly disregarded upon a showing that the corporation is a mere sham or dummy. Post Sign at 390 (citing Fidelity Trust Co. v. Service Laundry Co., 160 Tenn. 57, 22 S.W.2d 6 (1929)); see Dillard & Coffin Co. v. Richmond Cotton Oil Co., 140 Tenn. 290, 204 S.W. 758 (1918); Tennessee Consol. Coal Co. v. Home Ice & Coal Co., 25 TennApp. 316, 156 S.W.2d 454 (1941).

In Continental Bankers Life Ins. Co. of the South v. Bank of Alamo, the Tennessee Supreme Court established a three-part test to establish whether a corporation was a mere instrumentality of another corporation and therefore warranted piercing the corporate veil:

(1) The parent corporation, at the time of the transaction complained of, exercises complete dominion over its subsidiary, not only of finances, but of policy and business practice in respect to the transaction under attack, so that the corporate entity, as to that transaction, had no separate mind, will or existence of its own.
(2) Such control must have been used to commit fraud or wrong, to perpetuate the violation of a statutory or other positive legal duty, or a dishonest and unjust act in contravention of third parties’ rights.
(3) The aforesaid control and breach of duty must proximately cause the injury or unjust loss complained of.

578 S.W.2d 625, 632 (Tenn.1979) (emphasis added) (paraphrasing Lowendahl v. Baltimore & O.R. Co., 247 A.D. 144, 287 N.Y.S. 62 (1936)).

In Federal Deposit Ins. Corp. v. Allen, the United States District Court for the Eastern District of Tennessee provided an extensive list of additional factors that may be considered when deciding whether to pierce the corporate veil:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

T.H. v. Novartis Pharmaceuticals Corporation
407 P.3d 18 (California Supreme Court, 2017)
Smith v. PFIZER INC.
688 F. Supp. 2d 735 (M.D. Tennessee, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
144 F. Supp. 2d 958, 2000 U.S. Dist. LEXIS 19895, 2000 WL 33281615, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mcconkey-v-mcghan-medical-corp-tned-2000.